Nitrous Oxyde During Labour
NCT06595303 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 70
Last updated 2025-05-21
Summary
1. Background to the clinical research project Nitrous oxide is a valuable tool in medicine for its rapid and effective analgesic and sedative properties. It is used in 50% gaseous form for painful procedures. One frequent application is obstetric analgesia. However, in addition to its analgesic effects, many articles mention the psychotropic, even psychedelic, effects of nitrous oxide use. In one of the most recent studies, entitled More than just joy: A qualitative analysis of participant experiences during nitrous oxide sedation, involving healthy volunteers, it is reported that the sensations and feelings of the subjects are not necessarily pleasant, and many volunteers report psychedelic-like sensations, dreams or disturbed perceptions. The authors then question whether these effects are due to an absence of painful stimuli and therefore an absence of a beneficial effect. The same effects have been reported by Atkinson et al, also on volunteer subjects. Parturients feelings are highly variable, with a stronger focus on analgesic efficacy.
2. Objectives of the clinical research project 2.1 Primary objective: The main objective will be to evaluate the effects of nitrous oxide, other than analgesia, in the specific context of childbirth. The study will focus mainly on subjective feelings, as well as the effects of disconnection from reality.
2.2 Secondary objectives: As secondary objectives, we will study the efficacy on pain.
3. Methodology of the clinical research project All patients who have received nitrous oxide for delivery as part of the standard course of treatment in the delivery room will be contacted within 24 hours by one of the investigators. The protocol, i.e. the questionnaire, will be explained to the patients and, if they accept the protocol, written consent will be obtained. Patients will then complete the questionnaire in the presence of one of the investigators, who will be able to explain the questions if necessary. The questionnaire will take around 20 minutes to complete.
4. Design of the clinical research project Prospective study based on a questionnaire.
5. Participants Any person who received nitrous oxide for childbirth at Hôpital Érasme between October 1, 2024 and April 30, 2025 and who signed the informed consent form for this study.
Conditions
- Nitrous Oxide
- Labour Analgesia
Interventions
- DRUG
-
Nitrous oxide for labour analgesia
Any woman may choose to have nitrous oxide inhalation as a standard protocol for labour analgesia
Sponsors & Collaborators
-
Erasme University Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-11-05
- Primary Completion
- 2025-05-15
- Completion
- 2025-05-20
Countries
- Belgium
Study Locations
More Related Trials
-
In Vitro Myometrial Contractions in Laboring and Non-laboring Women
NCT01689311 ·Status: COMPLETED ·Phase: NA
-
Open Randomized Controlled Trial to Evaluate the Efficacy and Safety of Remifentanil Versus Nitrous Oxide in External Cephalic Version at Term in Singleton Pregnancy in Breech Presentation
NCT01735669 ·Status: COMPLETED ·Phase: PHASE3
-
The Relaxant Effect of Nitroglycerin on Oxytocin Desensitized Human Myometrium
NCT03408054 ·Status: COMPLETED ·Phase: NA
-
Comparing Sedara to Butorphanol in Early Labor
NCT01636999 ·Status: WITHDRAWN ·Phase: NA
-
Nitrous Oxide for Pain Management During In-Office Gynecology Procedures
NCT06661005 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Intraabdominal Chloroprocaine During Cesarean Delivery for Pain Control
NCT03260972 ·Status: WITHDRAWN ·Phase: PHASE3
-
Prophylactic Lidocaine Spray for Pain Alleviation in Women Undergoing Osmotic Dilator Insertion for Second Trimester Dilatation and Evacuation
NCT02097017 ·Status: COMPLETED ·Phase: PHASE4
-
Epidural Morphine for Analgesia After Traumatic Vaginal Delivery
NCT01689597 ·Status: WITHDRAWN ·Phase: PHASE4
-
Intrapartum Maternal Oxygen Supplementation: Effects on the Mother and Neonate
NCT03581214 ·Status: COMPLETED ·Phase: NA
-
The Impact of an Epidural Ropivacaine-Neostigmine Injection for Perineal Analgesia at the End of Labor.
NCT00407290 ·Status: UNKNOWN ·Phase: NA
-
The Effect of Hyoscine Butyl Bromide on the First Stage of Labor in Term Pregnancies
NCT00409890 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Ropivacaine Concentrations on Prolonged Labor Analgesia
NCT07007650 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Multicenter Study of Chloroprocaine Versus Ropivacaine for Epidural Labor Analgesia
NCT06472232 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Intracervical Balloon Placement With Nitrous Oxide Administration
NCT06498908 ·Status: WITHDRAWN ·Phase: PHASE3
-
Safety of Epidural Fentanyl and Adrenalin During Childbirth
NCT00685672 ·Status: COMPLETED ·Phase: PHASE4
-
Chloroprocaine 3% - Epidural Anesthesia in Unplanned Caesarean Section
NCT02919072 ·Status: TERMINATED ·Phase: PHASE3
-
Comparison of Two Methods of Administration of the Epidural, by Programmed Intermittent Bolus or Continuous Perfusion, on the Incidence of Cesarean Sections and Instrumented Deliveries in Primiparous Women
NCT02705872 ·Status: WITHDRAWN ·Phase: PHASE2
-
Active Versus Expectant Management of the Third Stage of Labor
NCT00473707 ·Status: COMPLETED ·Phase: NA
-
Nitrous Oxide for Pain Management During In-office Transcervical Sterilization
NCT02312739 ·Status: COMPLETED ·Phase: NA
-
Comparing High Versus Low Dose of Oxytocin, in Gravida Women With BMI 30 and Above Which Are Undergoing Induction of Labor
NCT06990217 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Up-Down Oxytocin Infusion
NCT00785395 ·Status: COMPLETED ·Phase: PHASE4
-
Role of Hyoscine Bromide in Latent and Active Labor
NCT02103166 ·Status: SUSPENDED ·Phase: PHASE4
-
Intracutaneous Sterile Water Injections
NCT01513447 ·Status: TERMINATED ·Phase: NA
-
The Effect of Hyoscine Butylbromide on Shortening of First and Second Stages of Labor
NCT02839213 ·Status: COMPLETED ·Phase: PHASE2
-
Sublingual Oxytocin for the Prevention of Post-partum Hemorrhage
NCT06968481 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2